|
Home : Unsafe Drugs : Avandia : News Articles : Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro
The peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist rosiglitazone has been suggested to exert cardiovascular protection through the improvement of lipid metabolism, anti-inflammation, anti-proliferation etc. However, whether renin-angiotensin system (RAS) is involved in the vascular protective effects ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




